Search for: "Mylan, Inc."
Results 21 - 40
of 672
Sort by Relevance
|
Sort by Date
10 Nov 2022, 1:25 pm
The Securities and Exchange Commission today announced insider trading charges against Ramkumar Rayapureddy, Chief Information Officer of pharmaceutical company Viatris Inc., which was formerly known as Mylan N.V. [read post]
1 Nov 2022, 7:50 am
Contractors of Cal., Inc. v. [read post]
5 Oct 2022, 8:12 pm
Patent No. 7,326,708 were either anticipated or rendered obvious by the asserted prior art, in Mylan Pharmaceuticals Inc. v. [read post]
4 Oct 2022, 11:47 am
Inc. v. [read post]
3 Oct 2022, 8:27 am
Mylan Pharmaceuticals Inc., No. 21-1567 [read post]
1 Oct 2022, 2:31 pm
The outcome: Mylan Pharmaceuticals Inc. [read post]
29 Sep 2022, 1:15 pm
Court of Appeals for the Federal Circuit (CAFC) earlier today upheld a Patent Trial and Appeal Board (PTAB) decision finding that Mylan Pharmaceuticals, Inc. failed to show that certain claims of Merck Sharp & Dohme Corp. [read post]
29 Sep 2022, 1:15 pm
Court of Appeals for the Federal Circuit (CAFC) earlier today upheld a Patent Trial and Appeal Board (PTAB) decision finding that Mylan Pharmaceuticals, Inc. failed to show that certain claims of Merck Sharp & Dohme Corp. [read post]
26 Sep 2022, 4:49 am
Mylan. [read post]
18 Aug 2022, 4:43 am
Suzanne prosecuted many notable FCA cases in the government, including several qui tam cases against National Medicare Care, Inc. [read post]
15 Aug 2022, 3:10 am
Early in July, Mylan Pharmaceuticals, Inc. voluntarily recalled a batch of its prefilled Insulin Glargine Injection pens that come in 100 units/mL, 3 mL. [read post]
5 Aug 2022, 5:00 am
In Myland, Inc. v. [read post]
21 Jul 2022, 9:15 am
Mylan Pharmaceuticals Inc. [read post]
21 Jul 2022, 9:15 am
Mylan Pharmaceuticals Inc. [read post]
18 Jul 2022, 2:00 am
Mylan, Inc. [read post]
3 Jul 2022, 6:50 pm
Mylan Pharmaceuticals Inc. 21-1567Issue: Whether 35 U.S.C. [read post]
1 Jul 2022, 10:02 am
Mylan Pharmaceuticals Inc., No. 21-1567, also focuses on the written description requirement – asking what level of disclosure is necessary for a claim limitation requiring a therapeutic treatment to be “effective. [read post]
16 Jun 2022, 9:15 am
Among those cases, note: Peter Pedersen has continued to add defendants to what promises to be a wide-ranging assertion campaign based on a single patent covering organizing email lists; Samsung has settled a tranche of IPRs against Trenchant Blade Technologies (associated with Tanit Ventures, Inc., with old patents, presumably with a backend, from Taiwan Semiconductor Manufacturing Corporation TSMC); Google filed more inter partes reviews (IPRs) against Jawbone (the failed company… [read post]
17 Mar 2022, 9:06 pm
Mylan Pharmaceuticals Inc. [read post]
17 Mar 2022, 2:32 pm
Mylan Pharmaceuticals Inc. [read post]
